4//SEC Filing
Benecchi Christopher 4
Accession 0001562180-23-001079
CIK 0001597553other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:10 PM ET
Size
8.7 KB
Accession
0001562180-23-001079
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2023-02-03$44.16/sh−2,119$93,575→ 5,260 total - Award
Common Stock
2023-02-03+6,750→ 7,379 total
Footnotes (2)
- [F1]On October 1, 2021, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 22,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on February 3, 2023, resulting in the vesting of the PSUs as to 6,750 shares.
- [F2]Reflects beneficial ownership balance which includes 414 shares purchased on June 30, 2022 and 215 shares purchased on December 31, 2022, each under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001881403
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:10 PM ET
- Size
- 8.7 KB